Literature DB >> 8267250

Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.

M S Lin1, E Tanner, J Lynn, G A Friday.   

Abstract

Skin testing and immunotherapy with allergens can induce systemic allergic reactions. In order to identify factors associated with systemic allergic reactions, a prospective study was conducted from 1976-1989 with more than 10,000 patients being tested and a total of 513,368 injections being recorded. Our study showed that the probability of inducing systemic allergic reactions by skin testing was less than 0.02% and the probability of systemic allergic reactions caused by immunotherapy was 2.9%. The female to male ratio was 3 to 2. The highest incidence of systemic allergic reactions was in patients between the ages of 16 to 39 years of age. The majority of systemic allergic reactions occurred when patients were on increasing doses rather than maintenance doses. More than 95% of systemic allergic reactions were associated with pollens and most of them happened between the concentration of 100 and 1000 PNU/mL. There was no increased incidence during grass or ragweed pollination seasons in those patients who received grass or ragweed injections during the respective seasons. Only 50% of systemic allergic reactions developed within 30 minutes after injections. The three most important factors determining the incidence of systemic allergic reactions are the type of allergens, the "rate" of increase of allergen concentrations, and sensitivity of the patients to allergens. The prick test at initial allergy assessment can be used to "rule out," with a high degree of certainty, the likelihood of systemic allergic reactions. The prick test is easy to perform and it is cost-effective. Prick tests and RAST together are helpful in identifying the patients and the allergens at higher risk of systemic allergic reactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267250

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  15 in total

Review 1.  Allergen immunotherapy.

Authors:  R E Esch; J Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

2.  Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy: year 2.

Authors:  Tolly G Epstein; Gary M Liss; Karen Murphy-Berendts; David I Bernstein
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-17       Impact factor: 6.347

Review 3.  Safety considerations in treating concomitant diseases in patients with asthma.

Authors:  L W Hunt
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 4.  The risk and management of anaphylaxis in the setting of immunotherapy.

Authors:  Phil Lieberman
Journal:  Am J Rhinol Allergy       Date:  2012 Nov-Dec       Impact factor: 2.467

Review 5.  Immunotherapy safety: what have we learned from surveillance surveys?

Authors:  Jennifer A Kannan; Tolly G Epstein
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

6.  The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.

Authors:  Frederick M Schaffer; Andrew R Naples; Myla Ebeling; Thomas C Hulsey; Larry M Garner
Journal:  Int Forum Allergy Rhinol       Date:  2014-12-04       Impact factor: 3.858

Review 7.  Immunotherapy in all aspects.

Authors:  Deniz Hanci; Ethem Şahin; Nuray Bayar Muluk; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-12       Impact factor: 2.503

8.  Evaluation of The Safety and Efficacy of Newly Developed Domestic Allergenic Extracts for Skin Prick Testing.

Authors:  Mohammad Fereidouni; Roya Mahdavi; Sarah Mahmoudzade; Hadis Rezapoor; Alireza Fereidouni; Afsane Bahrami
Journal:  Rep Biochem Mol Biol       Date:  2021-07

Review 9.  Fatalities following allergen immunotherapy.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

Review 10.  Peanut allergy: an overview.

Authors:  Saleh Al-Muhsen; Ann E Clarke; Rhoda S Kagan
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.